EUROPEAN JOURNAL OF RADIOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2265975, encodeId=598e22659e5d9, content=月初号投的，第二天编辑给了小意见，修回后with editor两周，然后under review4天后就是RRC，又等了半个月直接接收，比预期快很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=101a5563243, createdName=ms7000001656225584, createdTime=Wed May 21 10:34:15 CST 2025, time=2025-05-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2249992, encodeId=cd5d224999272, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2c98188501, createdName=ms8000001985502870, createdTime=Thu Jan 30 14:03:07 CST 2025, time=2025-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=892712, encodeId=3cec892e1201, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：核医学;NSCLC 经验分享：under rerview近三个月被拒，不过提了中肯的意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/14/1eec3230bf58688a20e7582ab818bef0.jpg, createdBy=c8dd1341384, createdName=lxhxixi, createdTime=Sat Oct 17 21:03:43 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241677, encodeId=d1b422416e724, content=审稿速度:6.0 经验分享：两个多月了还是with editor，催也没有用。不知道怎么办。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53085539089, createdName=ms3000001475892563, createdTime=Tue Dec 10 14:25:56 CST 2024, time=2024-12-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2236506, encodeId=015d223650606, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：放射 经验分享：很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=344e6510477, createdName=ms4000001619404291, createdTime=Tue Nov 12 14:21:59 CST 2024, time=2024-11-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2226479, encodeId=adc622264e9d7, content=非常慢，有史以来投过最慢的了，快2个月了还是with editor，准备撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fdf2386654, createdName=12325458m69(暂无昵称), createdTime=Wed Sep 18 18:19:55 CST 2024, time=2024-09-18, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2174742, encodeId=661a21e47426b, content=偏重的研究方向：影像临床研究 经验分享：太慢了，投稿一个月了还是With editor，啥时候能下一步啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41d38262744, createdName=ms3000001871892697, createdTime=Wed Dec 13 15:32:54 CST 2023, time=2023-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228747, encodeId=63881228e4705, content=投稿两周后由with editor变为decision in process，是不是要被拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9e28122545, createdName=ms1000000513449712, createdTime=Sun Jun 26 11:18:25 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199436, encodeId=c7181199436dd, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺放射学 经验分享：submitted：Sep 05, 2021 revision：Oct 15,2021 2th rexision: Dec 28, 2021 accepted：Mar 01, 2022 历时差不多6个月，中间因为authorship的问题经历了两个来回，有点浪费时间，感觉老牌杂志还是挺严谨的。审稿人和责编都挺专业的，给了一些很好的修改建议，很适合新手投稿的一个杂志。虽然漫长，但一投即中还是纪念一下吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9dd84960159, createdName=1540564381, createdTime=Fri Mar 04 17:29:50 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201857, encodeId=f308220185eee, content=二次审稿意见只提了润色问题，但是润色回去为啥又送审了啊？大家有没有这样的问题？过程太煎熬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ab78392302, createdName=ms9000000120476334, createdTime=Sun May 05 19:34:42 CST 2024, time=2024-05-05, status=1, ipAttribution=天津)]

2025-05-21 ms7000001656225584 来自广东省

月初号投的，第二天编辑给了小意见，修回后with editor两周，然后under review4天后就是RRC，又等了半个月直接接收，比预期快很多

23 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2265975, encodeId=598e22659e5d9, content=月初号投的，第二天编辑给了小意见，修回后with editor两周，然后under review4天后就是RRC，又等了半个月直接接收，比预期快很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=101a5563243, createdName=ms7000001656225584, createdTime=Wed May 21 10:34:15 CST 2025, time=2025-05-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2249992, encodeId=cd5d224999272, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2c98188501, createdName=ms8000001985502870, createdTime=Thu Jan 30 14:03:07 CST 2025, time=2025-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=892712, encodeId=3cec892e1201, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：核医学;NSCLC 经验分享：under rerview近三个月被拒，不过提了中肯的意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/14/1eec3230bf58688a20e7582ab818bef0.jpg, createdBy=c8dd1341384, createdName=lxhxixi, createdTime=Sat Oct 17 21:03:43 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241677, encodeId=d1b422416e724, content=审稿速度:6.0 经验分享：两个多月了还是with editor，催也没有用。不知道怎么办。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53085539089, createdName=ms3000001475892563, createdTime=Tue Dec 10 14:25:56 CST 2024, time=2024-12-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2236506, encodeId=015d223650606, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：放射 经验分享：很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=344e6510477, createdName=ms4000001619404291, createdTime=Tue Nov 12 14:21:59 CST 2024, time=2024-11-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2226479, encodeId=adc622264e9d7, content=非常慢，有史以来投过最慢的了，快2个月了还是with editor，准备撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fdf2386654, createdName=12325458m69(暂无昵称), createdTime=Wed Sep 18 18:19:55 CST 2024, time=2024-09-18, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2174742, encodeId=661a21e47426b, content=偏重的研究方向：影像临床研究 经验分享：太慢了，投稿一个月了还是With editor，啥时候能下一步啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41d38262744, createdName=ms3000001871892697, createdTime=Wed Dec 13 15:32:54 CST 2023, time=2023-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228747, encodeId=63881228e4705, content=投稿两周后由with editor变为decision in process，是不是要被拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9e28122545, createdName=ms1000000513449712, createdTime=Sun Jun 26 11:18:25 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199436, encodeId=c7181199436dd, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺放射学 经验分享：submitted：Sep 05, 2021 revision：Oct 15,2021 2th rexision: Dec 28, 2021 accepted：Mar 01, 2022 历时差不多6个月，中间因为authorship的问题经历了两个来回，有点浪费时间，感觉老牌杂志还是挺严谨的。审稿人和责编都挺专业的，给了一些很好的修改建议，很适合新手投稿的一个杂志。虽然漫长，但一投即中还是纪念一下吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9dd84960159, createdName=1540564381, createdTime=Fri Mar 04 17:29:50 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201857, encodeId=f308220185eee, content=二次审稿意见只提了润色问题，但是润色回去为啥又送审了啊？大家有没有这样的问题？过程太煎熬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ab78392302, createdName=ms9000000120476334, createdTime=Sun May 05 19:34:42 CST 2024, time=2024-05-05, status=1, ipAttribution=天津)]

2025-01-30 ms8000001985502870 来自四川省

。

24 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2265975, encodeId=598e22659e5d9, content=月初号投的，第二天编辑给了小意见，修回后with editor两周，然后under review4天后就是RRC，又等了半个月直接接收，比预期快很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=101a5563243, createdName=ms7000001656225584, createdTime=Wed May 21 10:34:15 CST 2025, time=2025-05-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2249992, encodeId=cd5d224999272, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2c98188501, createdName=ms8000001985502870, createdTime=Thu Jan 30 14:03:07 CST 2025, time=2025-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=892712, encodeId=3cec892e1201, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：核医学;NSCLC 经验分享：under rerview近三个月被拒，不过提了中肯的意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/14/1eec3230bf58688a20e7582ab818bef0.jpg, createdBy=c8dd1341384, createdName=lxhxixi, createdTime=Sat Oct 17 21:03:43 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241677, encodeId=d1b422416e724, content=审稿速度:6.0 经验分享：两个多月了还是with editor，催也没有用。不知道怎么办。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53085539089, createdName=ms3000001475892563, createdTime=Tue Dec 10 14:25:56 CST 2024, time=2024-12-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2236506, encodeId=015d223650606, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：放射 经验分享：很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=344e6510477, createdName=ms4000001619404291, createdTime=Tue Nov 12 14:21:59 CST 2024, time=2024-11-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2226479, encodeId=adc622264e9d7, content=非常慢，有史以来投过最慢的了，快2个月了还是with editor，准备撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fdf2386654, createdName=12325458m69(暂无昵称), createdTime=Wed Sep 18 18:19:55 CST 2024, time=2024-09-18, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2174742, encodeId=661a21e47426b, content=偏重的研究方向：影像临床研究 经验分享：太慢了，投稿一个月了还是With editor，啥时候能下一步啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41d38262744, createdName=ms3000001871892697, createdTime=Wed Dec 13 15:32:54 CST 2023, time=2023-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228747, encodeId=63881228e4705, content=投稿两周后由with editor变为decision in process，是不是要被拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9e28122545, createdName=ms1000000513449712, createdTime=Sun Jun 26 11:18:25 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199436, encodeId=c7181199436dd, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺放射学 经验分享：submitted：Sep 05, 2021 revision：Oct 15,2021 2th rexision: Dec 28, 2021 accepted：Mar 01, 2022 历时差不多6个月，中间因为authorship的问题经历了两个来回，有点浪费时间，感觉老牌杂志还是挺严谨的。审稿人和责编都挺专业的，给了一些很好的修改建议，很适合新手投稿的一个杂志。虽然漫长，但一投即中还是纪念一下吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9dd84960159, createdName=1540564381, createdTime=Fri Mar 04 17:29:50 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201857, encodeId=f308220185eee, content=二次审稿意见只提了润色问题，但是润色回去为啥又送审了啊？大家有没有这样的问题？过程太煎熬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ab78392302, createdName=ms9000000120476334, createdTime=Sun May 05 19:34:42 CST 2024, time=2024-05-05, status=1, ipAttribution=天津)]

2020-10-17 lxhxixi

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：核医学;NSCLC
经验分享：under rerview近三个月被拒，不过提了中肯的意见。

153 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2265975, encodeId=598e22659e5d9, content=月初号投的，第二天编辑给了小意见，修回后with editor两周，然后under review4天后就是RRC，又等了半个月直接接收，比预期快很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=101a5563243, createdName=ms7000001656225584, createdTime=Wed May 21 10:34:15 CST 2025, time=2025-05-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2249992, encodeId=cd5d224999272, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2c98188501, createdName=ms8000001985502870, createdTime=Thu Jan 30 14:03:07 CST 2025, time=2025-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=892712, encodeId=3cec892e1201, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：核医学;NSCLC 经验分享：under rerview近三个月被拒，不过提了中肯的意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/14/1eec3230bf58688a20e7582ab818bef0.jpg, createdBy=c8dd1341384, createdName=lxhxixi, createdTime=Sat Oct 17 21:03:43 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241677, encodeId=d1b422416e724, content=审稿速度:6.0 经验分享：两个多月了还是with editor，催也没有用。不知道怎么办。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53085539089, createdName=ms3000001475892563, createdTime=Tue Dec 10 14:25:56 CST 2024, time=2024-12-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2236506, encodeId=015d223650606, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：放射 经验分享：很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=344e6510477, createdName=ms4000001619404291, createdTime=Tue Nov 12 14:21:59 CST 2024, time=2024-11-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2226479, encodeId=adc622264e9d7, content=非常慢，有史以来投过最慢的了，快2个月了还是with editor，准备撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fdf2386654, createdName=12325458m69(暂无昵称), createdTime=Wed Sep 18 18:19:55 CST 2024, time=2024-09-18, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2174742, encodeId=661a21e47426b, content=偏重的研究方向：影像临床研究 经验分享：太慢了，投稿一个月了还是With editor，啥时候能下一步啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41d38262744, createdName=ms3000001871892697, createdTime=Wed Dec 13 15:32:54 CST 2023, time=2023-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228747, encodeId=63881228e4705, content=投稿两周后由with editor变为decision in process，是不是要被拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9e28122545, createdName=ms1000000513449712, createdTime=Sun Jun 26 11:18:25 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199436, encodeId=c7181199436dd, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺放射学 经验分享：submitted：Sep 05, 2021 revision：Oct 15,2021 2th rexision: Dec 28, 2021 accepted：Mar 01, 2022 历时差不多6个月，中间因为authorship的问题经历了两个来回，有点浪费时间，感觉老牌杂志还是挺严谨的。审稿人和责编都挺专业的，给了一些很好的修改建议，很适合新手投稿的一个杂志。虽然漫长，但一投即中还是纪念一下吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9dd84960159, createdName=1540564381, createdTime=Fri Mar 04 17:29:50 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201857, encodeId=f308220185eee, content=二次审稿意见只提了润色问题，但是润色回去为啥又送审了啊？大家有没有这样的问题？过程太煎熬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ab78392302, createdName=ms9000000120476334, createdTime=Sun May 05 19:34:42 CST 2024, time=2024-05-05, status=1, ipAttribution=天津)]

2024-12-10 ms3000001475892563 来自湖北省

审稿速度:6.0
经验分享：两个多月了还是with editor，催也没有用。不知道怎么办。

40 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2265975, encodeId=598e22659e5d9, content=月初号投的，第二天编辑给了小意见，修回后with editor两周，然后under review4天后就是RRC，又等了半个月直接接收，比预期快很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=101a5563243, createdName=ms7000001656225584, createdTime=Wed May 21 10:34:15 CST 2025, time=2025-05-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2249992, encodeId=cd5d224999272, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2c98188501, createdName=ms8000001985502870, createdTime=Thu Jan 30 14:03:07 CST 2025, time=2025-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=892712, encodeId=3cec892e1201, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：核医学;NSCLC 经验分享：under rerview近三个月被拒，不过提了中肯的意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/14/1eec3230bf58688a20e7582ab818bef0.jpg, createdBy=c8dd1341384, createdName=lxhxixi, createdTime=Sat Oct 17 21:03:43 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241677, encodeId=d1b422416e724, content=审稿速度:6.0 经验分享：两个多月了还是with editor，催也没有用。不知道怎么办。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53085539089, createdName=ms3000001475892563, createdTime=Tue Dec 10 14:25:56 CST 2024, time=2024-12-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2236506, encodeId=015d223650606, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：放射 经验分享：很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=344e6510477, createdName=ms4000001619404291, createdTime=Tue Nov 12 14:21:59 CST 2024, time=2024-11-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2226479, encodeId=adc622264e9d7, content=非常慢，有史以来投过最慢的了，快2个月了还是with editor，准备撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fdf2386654, createdName=12325458m69(暂无昵称), createdTime=Wed Sep 18 18:19:55 CST 2024, time=2024-09-18, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2174742, encodeId=661a21e47426b, content=偏重的研究方向：影像临床研究 经验分享：太慢了，投稿一个月了还是With editor，啥时候能下一步啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41d38262744, createdName=ms3000001871892697, createdTime=Wed Dec 13 15:32:54 CST 2023, time=2023-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228747, encodeId=63881228e4705, content=投稿两周后由with editor变为decision in process，是不是要被拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9e28122545, createdName=ms1000000513449712, createdTime=Sun Jun 26 11:18:25 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199436, encodeId=c7181199436dd, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺放射学 经验分享：submitted：Sep 05, 2021 revision：Oct 15,2021 2th rexision: Dec 28, 2021 accepted：Mar 01, 2022 历时差不多6个月，中间因为authorship的问题经历了两个来回，有点浪费时间，感觉老牌杂志还是挺严谨的。审稿人和责编都挺专业的，给了一些很好的修改建议，很适合新手投稿的一个杂志。虽然漫长，但一投即中还是纪念一下吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9dd84960159, createdName=1540564381, createdTime=Fri Mar 04 17:29:50 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201857, encodeId=f308220185eee, content=二次审稿意见只提了润色问题，但是润色回去为啥又送审了啊？大家有没有这样的问题？过程太煎熬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ab78392302, createdName=ms9000000120476334, createdTime=Sun May 05 19:34:42 CST 2024, time=2024-05-05, status=1, ipAttribution=天津)]

2024-11-12 ms4000001619404291 来自上海

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：放射
经验分享：很慢

49 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2265975, encodeId=598e22659e5d9, content=月初号投的，第二天编辑给了小意见，修回后with editor两周，然后under review4天后就是RRC，又等了半个月直接接收，比预期快很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=101a5563243, createdName=ms7000001656225584, createdTime=Wed May 21 10:34:15 CST 2025, time=2025-05-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2249992, encodeId=cd5d224999272, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2c98188501, createdName=ms8000001985502870, createdTime=Thu Jan 30 14:03:07 CST 2025, time=2025-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=892712, encodeId=3cec892e1201, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：核医学;NSCLC 经验分享：under rerview近三个月被拒，不过提了中肯的意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/14/1eec3230bf58688a20e7582ab818bef0.jpg, createdBy=c8dd1341384, createdName=lxhxixi, createdTime=Sat Oct 17 21:03:43 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241677, encodeId=d1b422416e724, content=审稿速度:6.0 经验分享：两个多月了还是with editor，催也没有用。不知道怎么办。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53085539089, createdName=ms3000001475892563, createdTime=Tue Dec 10 14:25:56 CST 2024, time=2024-12-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2236506, encodeId=015d223650606, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：放射 经验分享：很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=344e6510477, createdName=ms4000001619404291, createdTime=Tue Nov 12 14:21:59 CST 2024, time=2024-11-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2226479, encodeId=adc622264e9d7, content=非常慢，有史以来投过最慢的了，快2个月了还是with editor，准备撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fdf2386654, createdName=12325458m69(暂无昵称), createdTime=Wed Sep 18 18:19:55 CST 2024, time=2024-09-18, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2174742, encodeId=661a21e47426b, content=偏重的研究方向：影像临床研究 经验分享：太慢了，投稿一个月了还是With editor，啥时候能下一步啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41d38262744, createdName=ms3000001871892697, createdTime=Wed Dec 13 15:32:54 CST 2023, time=2023-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228747, encodeId=63881228e4705, content=投稿两周后由with editor变为decision in process，是不是要被拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9e28122545, createdName=ms1000000513449712, createdTime=Sun Jun 26 11:18:25 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199436, encodeId=c7181199436dd, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺放射学 经验分享：submitted：Sep 05, 2021 revision：Oct 15,2021 2th rexision: Dec 28, 2021 accepted：Mar 01, 2022 历时差不多6个月，中间因为authorship的问题经历了两个来回，有点浪费时间，感觉老牌杂志还是挺严谨的。审稿人和责编都挺专业的，给了一些很好的修改建议，很适合新手投稿的一个杂志。虽然漫长，但一投即中还是纪念一下吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9dd84960159, createdName=1540564381, createdTime=Fri Mar 04 17:29:50 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201857, encodeId=f308220185eee, content=二次审稿意见只提了润色问题，但是润色回去为啥又送审了啊？大家有没有这样的问题？过程太煎熬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ab78392302, createdName=ms9000000120476334, createdTime=Sun May 05 19:34:42 CST 2024, time=2024-05-05, status=1, ipAttribution=天津)]

2024-09-18 12325458m69(暂无昵称) 来自福建省

非常慢，有史以来投过最慢的了，快2个月了还是with editor，准备撤稿

62 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2265975, encodeId=598e22659e5d9, content=月初号投的，第二天编辑给了小意见，修回后with editor两周，然后under review4天后就是RRC，又等了半个月直接接收，比预期快很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=101a5563243, createdName=ms7000001656225584, createdTime=Wed May 21 10:34:15 CST 2025, time=2025-05-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2249992, encodeId=cd5d224999272, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2c98188501, createdName=ms8000001985502870, createdTime=Thu Jan 30 14:03:07 CST 2025, time=2025-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=892712, encodeId=3cec892e1201, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：核医学;NSCLC 经验分享：under rerview近三个月被拒，不过提了中肯的意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/14/1eec3230bf58688a20e7582ab818bef0.jpg, createdBy=c8dd1341384, createdName=lxhxixi, createdTime=Sat Oct 17 21:03:43 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241677, encodeId=d1b422416e724, content=审稿速度:6.0 经验分享：两个多月了还是with editor，催也没有用。不知道怎么办。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53085539089, createdName=ms3000001475892563, createdTime=Tue Dec 10 14:25:56 CST 2024, time=2024-12-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2236506, encodeId=015d223650606, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：放射 经验分享：很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=344e6510477, createdName=ms4000001619404291, createdTime=Tue Nov 12 14:21:59 CST 2024, time=2024-11-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2226479, encodeId=adc622264e9d7, content=非常慢，有史以来投过最慢的了，快2个月了还是with editor，准备撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fdf2386654, createdName=12325458m69(暂无昵称), createdTime=Wed Sep 18 18:19:55 CST 2024, time=2024-09-18, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2174742, encodeId=661a21e47426b, content=偏重的研究方向：影像临床研究 经验分享：太慢了，投稿一个月了还是With editor，啥时候能下一步啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41d38262744, createdName=ms3000001871892697, createdTime=Wed Dec 13 15:32:54 CST 2023, time=2023-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228747, encodeId=63881228e4705, content=投稿两周后由with editor变为decision in process，是不是要被拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9e28122545, createdName=ms1000000513449712, createdTime=Sun Jun 26 11:18:25 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199436, encodeId=c7181199436dd, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺放射学 经验分享：submitted：Sep 05, 2021 revision：Oct 15,2021 2th rexision: Dec 28, 2021 accepted：Mar 01, 2022 历时差不多6个月，中间因为authorship的问题经历了两个来回，有点浪费时间，感觉老牌杂志还是挺严谨的。审稿人和责编都挺专业的，给了一些很好的修改建议，很适合新手投稿的一个杂志。虽然漫长，但一投即中还是纪念一下吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9dd84960159, createdName=1540564381, createdTime=Fri Mar 04 17:29:50 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201857, encodeId=f308220185eee, content=二次审稿意见只提了润色问题，但是润色回去为啥又送审了啊？大家有没有这样的问题？过程太煎熬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ab78392302, createdName=ms9000000120476334, createdTime=Sun May 05 19:34:42 CST 2024, time=2024-05-05, status=1, ipAttribution=天津)]

2023-12-13 ms3000001871892697

偏重的研究方向：影像临床研究
经验分享：太慢了，投稿一个月了还是With editor，啥时候能下一步啊

144 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2265975, encodeId=598e22659e5d9, content=月初号投的，第二天编辑给了小意见，修回后with editor两周，然后under review4天后就是RRC，又等了半个月直接接收，比预期快很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=101a5563243, createdName=ms7000001656225584, createdTime=Wed May 21 10:34:15 CST 2025, time=2025-05-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2249992, encodeId=cd5d224999272, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2c98188501, createdName=ms8000001985502870, createdTime=Thu Jan 30 14:03:07 CST 2025, time=2025-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=892712, encodeId=3cec892e1201, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：核医学;NSCLC 经验分享：under rerview近三个月被拒，不过提了中肯的意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/14/1eec3230bf58688a20e7582ab818bef0.jpg, createdBy=c8dd1341384, createdName=lxhxixi, createdTime=Sat Oct 17 21:03:43 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241677, encodeId=d1b422416e724, content=审稿速度:6.0 经验分享：两个多月了还是with editor，催也没有用。不知道怎么办。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53085539089, createdName=ms3000001475892563, createdTime=Tue Dec 10 14:25:56 CST 2024, time=2024-12-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2236506, encodeId=015d223650606, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：放射 经验分享：很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=344e6510477, createdName=ms4000001619404291, createdTime=Tue Nov 12 14:21:59 CST 2024, time=2024-11-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2226479, encodeId=adc622264e9d7, content=非常慢，有史以来投过最慢的了，快2个月了还是with editor，准备撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fdf2386654, createdName=12325458m69(暂无昵称), createdTime=Wed Sep 18 18:19:55 CST 2024, time=2024-09-18, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2174742, encodeId=661a21e47426b, content=偏重的研究方向：影像临床研究 经验分享：太慢了，投稿一个月了还是With editor，啥时候能下一步啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41d38262744, createdName=ms3000001871892697, createdTime=Wed Dec 13 15:32:54 CST 2023, time=2023-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228747, encodeId=63881228e4705, content=投稿两周后由with editor变为decision in process，是不是要被拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9e28122545, createdName=ms1000000513449712, createdTime=Sun Jun 26 11:18:25 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199436, encodeId=c7181199436dd, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺放射学 经验分享：submitted：Sep 05, 2021 revision：Oct 15,2021 2th rexision: Dec 28, 2021 accepted：Mar 01, 2022 历时差不多6个月，中间因为authorship的问题经历了两个来回，有点浪费时间，感觉老牌杂志还是挺严谨的。审稿人和责编都挺专业的，给了一些很好的修改建议，很适合新手投稿的一个杂志。虽然漫长，但一投即中还是纪念一下吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9dd84960159, createdName=1540564381, createdTime=Fri Mar 04 17:29:50 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201857, encodeId=f308220185eee, content=二次审稿意见只提了润色问题，但是润色回去为啥又送审了啊？大家有没有这样的问题？过程太煎熬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ab78392302, createdName=ms9000000120476334, createdTime=Sun May 05 19:34:42 CST 2024, time=2024-05-05, status=1, ipAttribution=天津)]

2022-06-26 ms1000000513449712

投稿两周后由with editor变为decision in process，是不是要被拒了啊

156 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2265975, encodeId=598e22659e5d9, content=月初号投的，第二天编辑给了小意见，修回后with editor两周，然后under review4天后就是RRC，又等了半个月直接接收，比预期快很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=101a5563243, createdName=ms7000001656225584, createdTime=Wed May 21 10:34:15 CST 2025, time=2025-05-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2249992, encodeId=cd5d224999272, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2c98188501, createdName=ms8000001985502870, createdTime=Thu Jan 30 14:03:07 CST 2025, time=2025-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=892712, encodeId=3cec892e1201, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：核医学;NSCLC 经验分享：under rerview近三个月被拒，不过提了中肯的意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/14/1eec3230bf58688a20e7582ab818bef0.jpg, createdBy=c8dd1341384, createdName=lxhxixi, createdTime=Sat Oct 17 21:03:43 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241677, encodeId=d1b422416e724, content=审稿速度:6.0 经验分享：两个多月了还是with editor，催也没有用。不知道怎么办。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53085539089, createdName=ms3000001475892563, createdTime=Tue Dec 10 14:25:56 CST 2024, time=2024-12-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2236506, encodeId=015d223650606, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：放射 经验分享：很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=344e6510477, createdName=ms4000001619404291, createdTime=Tue Nov 12 14:21:59 CST 2024, time=2024-11-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2226479, encodeId=adc622264e9d7, content=非常慢，有史以来投过最慢的了，快2个月了还是with editor，准备撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fdf2386654, createdName=12325458m69(暂无昵称), createdTime=Wed Sep 18 18:19:55 CST 2024, time=2024-09-18, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2174742, encodeId=661a21e47426b, content=偏重的研究方向：影像临床研究 经验分享：太慢了，投稿一个月了还是With editor，啥时候能下一步啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41d38262744, createdName=ms3000001871892697, createdTime=Wed Dec 13 15:32:54 CST 2023, time=2023-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228747, encodeId=63881228e4705, content=投稿两周后由with editor变为decision in process，是不是要被拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9e28122545, createdName=ms1000000513449712, createdTime=Sun Jun 26 11:18:25 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199436, encodeId=c7181199436dd, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺放射学 经验分享：submitted：Sep 05, 2021 revision：Oct 15,2021 2th rexision: Dec 28, 2021 accepted：Mar 01, 2022 历时差不多6个月，中间因为authorship的问题经历了两个来回，有点浪费时间，感觉老牌杂志还是挺严谨的。审稿人和责编都挺专业的，给了一些很好的修改建议，很适合新手投稿的一个杂志。虽然漫长，但一投即中还是纪念一下吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9dd84960159, createdName=1540564381, createdTime=Fri Mar 04 17:29:50 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201857, encodeId=f308220185eee, content=二次审稿意见只提了润色问题，但是润色回去为啥又送审了啊？大家有没有这样的问题？过程太煎熬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ab78392302, createdName=ms9000000120476334, createdTime=Sun May 05 19:34:42 CST 2024, time=2024-05-05, status=1, ipAttribution=天津)]

2022-03-04 1540564381

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：乳腺放射学
经验分享：submitted：Sep 05, 2021
revision：Oct 15,2021
2th rexision: Dec 28, 2021
accepted：Mar 01, 2022
历时差不多6个月，中间因为authorship的问题经历了两个来回，有点浪费时间，感觉老牌杂志还是挺严谨的。审稿人和责编都挺专业的，给了一些很好的修改建议，很适合新手投稿的一个杂志。虽然漫长，但一投即中还是纪念一下吧！

136 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2265975, encodeId=598e22659e5d9, content=月初号投的，第二天编辑给了小意见，修回后with editor两周，然后under review4天后就是RRC，又等了半个月直接接收，比预期快很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=101a5563243, createdName=ms7000001656225584, createdTime=Wed May 21 10:34:15 CST 2025, time=2025-05-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2249992, encodeId=cd5d224999272, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2c98188501, createdName=ms8000001985502870, createdTime=Thu Jan 30 14:03:07 CST 2025, time=2025-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=892712, encodeId=3cec892e1201, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：核医学;NSCLC 经验分享：under rerview近三个月被拒，不过提了中肯的意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/14/1eec3230bf58688a20e7582ab818bef0.jpg, createdBy=c8dd1341384, createdName=lxhxixi, createdTime=Sat Oct 17 21:03:43 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2241677, encodeId=d1b422416e724, content=审稿速度:6.0 经验分享：两个多月了还是with editor，催也没有用。不知道怎么办。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53085539089, createdName=ms3000001475892563, createdTime=Tue Dec 10 14:25:56 CST 2024, time=2024-12-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2236506, encodeId=015d223650606, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：放射 经验分享：很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=344e6510477, createdName=ms4000001619404291, createdTime=Tue Nov 12 14:21:59 CST 2024, time=2024-11-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2226479, encodeId=adc622264e9d7, content=非常慢，有史以来投过最慢的了，快2个月了还是with editor，准备撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fdf2386654, createdName=12325458m69(暂无昵称), createdTime=Wed Sep 18 18:19:55 CST 2024, time=2024-09-18, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2174742, encodeId=661a21e47426b, content=偏重的研究方向：影像临床研究 经验分享：太慢了，投稿一个月了还是With editor，啥时候能下一步啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41d38262744, createdName=ms3000001871892697, createdTime=Wed Dec 13 15:32:54 CST 2023, time=2023-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228747, encodeId=63881228e4705, content=投稿两周后由with editor变为decision in process，是不是要被拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9e28122545, createdName=ms1000000513449712, createdTime=Sun Jun 26 11:18:25 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199436, encodeId=c7181199436dd, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺放射学 经验分享：submitted：Sep 05, 2021 revision：Oct 15,2021 2th rexision: Dec 28, 2021 accepted：Mar 01, 2022 历时差不多6个月，中间因为authorship的问题经历了两个来回，有点浪费时间，感觉老牌杂志还是挺严谨的。审稿人和责编都挺专业的，给了一些很好的修改建议，很适合新手投稿的一个杂志。虽然漫长，但一投即中还是纪念一下吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9dd84960159, createdName=1540564381, createdTime=Fri Mar 04 17:29:50 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201857, encodeId=f308220185eee, content=二次审稿意见只提了润色问题，但是润色回去为啥又送审了啊？大家有没有这样的问题？过程太煎熬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ab78392302, createdName=ms9000000120476334, createdTime=Sun May 05 19:34:42 CST 2024, time=2024-05-05, status=1, ipAttribution=天津)]

2024-05-05 ms9000000120476334 来自天津

二次审稿意见只提了润色问题，但是润色回去为啥又送审了啊？大家有没有这样的问题？过程太煎熬了

111 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务